SKY-0515 showed a 1.59-point Huntington’s disease benefit, but can Skyhawk confirm it?
Skyhawk begins US dosing in pivotal FALCON-HD trials of SKY-0515, testing whether early Huntington's disease signals translate into clinical benefit.
Pharma & Biotech